Madrigal Pharmaceuticals broke new ground earlier this year as its Rezdiffra became the first drug approved by the FDA to ...

GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. On ...

Astellas is closing a gene therapy manufacturing facility in South San Francisco. But, across the country, the company opened ...

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. Fierce ...

A year after missing on a trial endpoint, Travere Therapeutics can breathe a sigh a relief. | A year after missing on a trial ...

After running up against a roadblock earlier this summer, the controversial BIOSECURE Act could gain new momentum next week.

After years of documentation and industry neglect, the World Health Organization (WHO) issued its first-ever guidance aimed ...

After handing over $30 million in criminal penalties last summer, Glenmark Pharmaceuticals has agreed to settle with the U.S.

Even though dementia is widespread—with more than 55 million people around the world currently affected and 10 million new ...

With dwindling funds after a prior snub from the FDA, ImmunityBio’s journey to bag approval for its Merck-rivaling bladder ...

By adding $1.1 billion to its settlement proposal, Johnson & Johnson is inching closer to resolving approximately 62,000 personal injury lawsuits from those who claim their cancers were caused by the ...

It’s as you were at the top of the TV drug ad spending table as AbbVie continues its 2024 domination as total spending across ...